Kul Raj Rai

Dr. Kul Raj Rai

School of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2019 in Cellular Microbiology
Verified
Journal Article
Closed access
PDF file
MMMohamed Maarouf
Mohamed Maarouf
BCBiao Chen
Biao Chen
YCYuhai Chen
Yuhai Chen
XWXuefei Wang
Xuefei Wang
KRKul Raj Rai
Kul Raj Rai
JCJi-Long Chen
Ji-Long Chen

22 June 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
KRKul Raj Rai
Kul Raj Rai
PSPrasha Shrestha
Prasha Shrestha
BYBincai Yang
Bincai Yang
YCYuhai Chen
Yuhai Chen
SLShasha Liu
Shasha Liu
JCJi-Long Chen
Ji-Long Chen
Viral infections can cause rampant disease in human beings, ranging from mild to acute, that can often be fatal unless resolved. An acute viral infection is characterized by sudden or rapid onset of disease, which can be resolved quickly by robust innate immune responses exerted by the host or, instead, may kill the host. Immediately after viral infection, elements of innate immunity, such as physical barriers, various phagocytic cells, group of cytokines, interferons (IFNs), and IFN-stimulated genes, provide the first line of defense for viral clearance. Innate immunity not only plays a critical role in rapid viral clearance but can also lead to disease progression through immune-mediated host tissue injury. Although elements of antiviral innate immunity are armed to counter the viral invasion, viruses have evolved various strategies to escape host immune surveillance to establish successful infections. Understanding complex mechanisms underlying the interaction between viruses and host’s innate immune system would help develop rational treatment strategies for acute viral infectious diseases. In this review, we discuss the pathogenesis of acute infections caused by viral pathogens and highlight broad immune escape strategies exhibited by viruses.

11 March 2021 in Tropical Medicine and Health
Verified
Journal Article
Open access
PDF file
ASAryatara Shilpakar
Aryatara Shilpakar
MAMehraj Ansari
Mehraj Ansari
KRKul Raj Rai
Kul Raj Rai
GRGanesh Rai
Ganesh Rai
SRShiba Kumar Rai
Shiba Kumar Rai
Background: The existence of multidrug-resistant organisms, including extended-spectrum beta-lactamases (ESBLs), is on rise across the globe and is becoming a severe problem. Knowledge of the prevalence and antibiogram profile of such isolates is essential to develop an appropriate treatment methodology. This study aimed to study the prevalence of Gram-negative isolates exhibiting ESBL at a tertiary care hospital and study their antibiogram profile. Methods: A cross-sectional study was conducted at Shahid Gangalal National Heart Centre, Kathmandu, Nepal, from June 2018 to November 2018. A total of 770 clinical samples were collected and identified using the conventional biochemical tests following the Clinical and Laboratory Standard Institute (CLSI) guidelines. Antimicrobial susceptibility testing (AST) was performed using the standardized Kirby-Bauer disk diffusion method. The screening test for ESBL producers was performed as recommended by the CLSI and the confirmatory test was performed phenotypically using the E-test. Results: Out of the 92 isolates, 84 (91.3%) were multidrug-resistant, and 47 (51.1%) were found to be potential ESBL producers. Of these, 16 isolates were confirmed ESBL producers by the E-test. Escherichia coli and Klebsiella pneumoniae were the predominant isolates and were also the major ESBL producers. Besides polymyxin B (100% sensitive), meropenem and imipenem showed high efficacy against the ESBL producers. Conclusion: Multidrug resistance was very high; however, ESBL production was low. Polymyxin B and carbapenems are the choice of drugs against ESBL producers but should be used only as the last line drugs.

13 October 2021 in Journal of Virology
Verified
Journal Article
Closed access
MXMeng Xiao
Meng Xiao
YCYuhai Chen
Yuhai Chen
SWSong Wang
Song Wang
SLShasha Liu
Shasha Liu
KRKul Raj Rai
Kul Raj Rai
JCJi-Long Chen
Ji-Long Chen
LncRNAs play important roles in various biological processes, but their involvement in host antiviral responses remains largely unknown. In this study, we revealed that the pseudogene IFITM4P belonging to the IFITM family can transcribe a functional long noncoding RNA termed lncRNA IFITM4P.

20 December 2022 in mBio
Verified
Journal Article
Open access
KRKul Raj Rai
Kul Raj Rai
YLYuan Liao
Yuan Liao
MCMengjuan Cai
Mengjuan Cai
HQHaori Qiu
Haori Qiu
FWFaxin Wen
Faxin Wen
JCJi-Long Chen
Ji-Long Chen
Here, we found that lncRNA-155KO mice lacking most of the lncRNA-155 sequences along with pre-miRNA-155, were more susceptible to influenza virus or pseudorabies virus infection than miRNA-155KO mice lacking only 19 bp of the miRNA-155 core sequence without affecting the expression of lncRNA-155, as evidenced by faster body weight loss, poorer survival, and higher viral load, suggesting an additional role of lncRNA-155 in regulating viral pathogenesis besides via processing miRNA-155. Congruously, miRNA-155-deleted lncRNA-155 significantly attenuated the viral infection.

1 April 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
RRRaksha Rimal
Raksha Rimal
DSDhiraj Shrestha
Dhiraj Shrestha
SPSusil Pyakurel
Susil Pyakurel
RPRashmi Poudel
Rashmi Poudel
PSPrasha Shrestha
Prasha Shrestha
SRShiba Kumar Rai
Shiba Kumar Rai
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide. Control of TB is lingering by the lack of diagnostic tests that are simple, rapid, yet accurate. Thus, smear-negative pulmonary TB often misses the diagnosis. The study evaluated the performance of GeneXpert MTB/RIF assay for the detection of Mycobacterium tuberculosis (MTB). Methods: The study was carried out from June to December 2016 in Nepal Tuberculosis Center, Bhaktapur, Nepal. A total of 173 sputum samples were collected and processed by microscopy [Auramine-O staining and Ziehl–Neelsen (ZN) staining], followed by GeneXpert MTB/RIF assay and culture in Lowenstein-Jensen (LJ) medium. Results: Of 173 sputum samples, 162 (93.6%) were smear-negative. Of 162 smear-negative sputum samples, 35 (21.6%) were confirmed to have MTB by culture, and 31 (19.1%) by GeneXpert MTB/RIF assay. Of 31 GeneXpert-positive samples, 25 (80.6%) were susceptible, 4 (12.9%) were resistant, and 2 (6.45%) were intermediate to rifampicin. The sensitivity, specificity, positive predictive value, and negative predictive value of GeneXpert MTB/RIF assay for smear-negative sputum samples were 74.3%, 96.6%, 86.7%, and 92%, respectively. The GeneXpert MTB/RIF has a substantial diagnostic agreement of 90.91% with culture (Cohen’s Kappa coefficient = 0.73). Conclusion: The diagnostic performance of GeneXpert MTB/RIF assay was almost on par with culture, and thus can be relied upon for MTB detection in smear-negative sputum samples.